Touchstone International Medical Science Co., Ltd. (SHA:688013)
China
· Delayed Price · Currency is CNY 20.13
+0.73 (3.76%)
Apr 30, 2025, 3:00 PM CST
SHA:688013 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Operating Revenue | 272.37 | 253.6 | 231.73 | 213.74 | 163.34 | Upgrade
|
| Other Revenue | - | 0.04 | 0.31 | 0 | 0 | Upgrade
|
| Revenue | 272.37 | 253.65 | 232.03 | 213.74 | 163.34 | Upgrade
|
| Revenue Growth (YoY) | 7.38% | 9.31% | 8.56% | 30.85% | -5.45% | Upgrade
|
| Cost of Revenue | 113.07 | 111.8 | 99.8 | 91.27 | 68.25 | Upgrade
|
| Gross Profit | 159.3 | 141.85 | 132.23 | 122.47 | 95.09 | Upgrade
|
| Selling, General & Admin | 74.89 | 71.9 | 61.66 | 62.37 | 48.47 | Upgrade
|
| Research & Development | 35.99 | 35.32 | 34.75 | 29.28 | 15.37 | Upgrade
|
| Other Operating Expenses | -0.04 | 2.66 | 2.39 | 2.13 | 1.35 | Upgrade
|
| Operating Expenses | 110.85 | 110.19 | 98.97 | 94.05 | 65.27 | Upgrade
|
| Operating Income | 48.45 | 31.66 | 33.27 | 28.41 | 29.82 | Upgrade
|
| Interest Expense | - | -0.09 | -0.16 | - | - | Upgrade
|
| Interest & Investment Income | 6.57 | 8.03 | 4.76 | 11.15 | 2.26 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 2.47 | 3.94 | 4 | 1.8 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.05 | -0.11 | -0.12 | -0.06 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | 57.06 | 41.97 | 41.69 | 43.51 | 33.79 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.89 | 4.06 | 2.09 | 0.44 | 0.56 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0 | 0.02 | 0.52 | -0 | Upgrade
|
| Asset Writedown | -0.34 | - | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | -1.08 | - | Upgrade
|
| Other Unusual Items | - | 1.92 | 2.28 | 2.71 | 5.85 | Upgrade
|
| Pretax Income | 54.83 | 47.95 | 46.08 | 46.09 | 40.2 | Upgrade
|
| Income Tax Expense | 2.94 | 0.64 | 2.89 | 4.67 | 5.25 | Upgrade
|
| Net Income | 51.89 | 47.31 | 43.2 | 41.42 | 34.95 | Upgrade
|
| Net Income to Common | 51.89 | 47.31 | 43.2 | 41.42 | 34.95 | Upgrade
|
| Net Income Growth | 9.69% | 9.53% | 4.29% | 18.52% | -16.80% | Upgrade
|
| Shares Outstanding (Basic) | 80 | 79 | 80 | 80 | 65 | Upgrade
|
| Shares Outstanding (Diluted) | 81 | 82 | 82 | 81 | 65 | Upgrade
|
| Shares Change (YoY) | -0.60% | 0.09% | 0.35% | 25.49% | 7.85% | Upgrade
|
| EPS (Basic) | 0.65 | 0.60 | 0.54 | 0.52 | 0.54 | Upgrade
|
| EPS (Diluted) | 0.64 | 0.58 | 0.53 | 0.51 | 0.54 | Upgrade
|
| EPS Growth | 10.35% | 9.43% | 3.92% | -5.56% | -22.86% | Upgrade
|
| Free Cash Flow | 11.47 | 64.54 | 2.73 | 51.77 | 34.79 | Upgrade
|
| Free Cash Flow Per Share | 0.14 | 0.79 | 0.03 | 0.64 | 0.54 | Upgrade
|
| Dividend Per Share | - | - | 0.250 | 0.200 | 0.200 | Upgrade
|
| Dividend Growth | - | - | 25.00% | - | - | Upgrade
|
| Gross Margin | 58.49% | 55.92% | 56.99% | 57.30% | 58.22% | Upgrade
|
| Operating Margin | 17.79% | 12.48% | 14.34% | 13.29% | 18.25% | Upgrade
|
| Profit Margin | 19.05% | 18.65% | 18.62% | 19.38% | 21.39% | Upgrade
|
| Free Cash Flow Margin | 4.21% | 25.44% | 1.18% | 24.22% | 21.30% | Upgrade
|
| EBITDA | 58.09 | 40.59 | 41.35 | 35.64 | 36.36 | Upgrade
|
| EBITDA Margin | 21.33% | 16.00% | 17.82% | 16.67% | 22.26% | Upgrade
|
| D&A For EBITDA | 9.64 | 8.92 | 8.09 | 7.22 | 6.54 | Upgrade
|
| EBIT | 48.45 | 31.66 | 33.27 | 28.41 | 29.82 | Upgrade
|
| EBIT Margin | 17.79% | 12.48% | 14.34% | 13.29% | 18.25% | Upgrade
|
| Effective Tax Rate | 5.36% | 1.33% | 6.27% | 10.14% | 13.07% | Upgrade
|
| Revenue as Reported | - | 253.65 | 232.03 | 213.74 | 163.34 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.